Advanced Search

Show simple item record

dc.contributor.authorDalar, Levent
dc.contributor.authorOzdemir, Cengiz
dc.contributor.authorAbul, Yasin
dc.contributor.authorSokucu, Sinem Nedime
dc.contributor.authorKarasulu, Levent
dc.contributor.authorUrer, Halide Nur
dc.contributor.authorAltin, Sedat
dc.date.accessioned2019-08-13T12:10:23Z
dc.date.accessioned2019-08-13T15:57:29Z
dc.date.available2019-08-13T12:10:23Z
dc.date.available2019-08-13T15:57:29Z
dc.date.issued2016
dc.identifier.issn0171-6425
dc.identifier.issn1439-1902
dc.identifier.urihttps://dx.doi.org/10.1055/s-0035-1549274
dc.identifier.urihttp://hdl.handle.net/11446/2525
dc.descriptionWOS: 000372020300013en_US
dc.descriptionPubMed ID: 25984778en_US
dc.description.abstractBackground Bronchial carcinoid tumors are known as low-grade malignancies. Surgery has been proposed as the best treatment of choice for lung carcinoids. However, less invasive treatment approaches may be considered due to low-grade malignancy potential of such tumors. The aim of this study was to review the results of endobronchial treatments of carcinoid tumors of the lung and to compare with the outcome after surgery. Methods Initial complete tumor eradication with an endobronchial treatment was attempted for 29 patients. Diode laser or argon plasma coagulation was used during these treatments. Cryotherapy or laser treatments were applied consecutively in patients for whom there was good bronchoscopic visualization of the distal and basal tumor margins and no evidence of bronchial wall involvement. Surgery was performed in cases of atypical carcinoid and in cases of nonvisualization of the basal and distal part of the tumor. Results Overall, 29 patients have been included (median age 58 years; range, 23-77 years). Median follow-up has been 49 months (range, 22-94 months). A total of 24 patients (69%) had typical carcinoid tumor, 5 patients (31%) had atypical carcinoid tumor. Initial endobronchial treatment provided complete tumor eradication in 21 of 29 patients (72%). Of the eight other patients (28%), two were atypical carcinoids, and underwent surgical treatment. There was no tumor-related death and no recurrence during the follow-up in both groups. There was no difference for survival or recurrence between the surgical and the endobronchial treatment group of patients (p > 0.05). Conclusion Endobronchial treatment may be considered as safe, effective treatment for typical carcinoid tumors in the central airways. Addition of initial endobronchial treatment had no negative effect on the surgical outcome.en_US
dc.language.isoengen_US
dc.publisherGEORG THIEME VERLAG KGen_US
dc.relation.isversionof10.1055/s-0035-1549274en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectcarcinoid tumorsen_US
dc.subjectlungen_US
dc.subjectendobronchial treatmenten_US
dc.titleEndobronchial Treatment of Carcinoid Tumors of the Lungen_US
dc.typearticleen_US
dc.relation.journalTHORACIC AND CARDIOVASCULAR SURGEONen_US
dc.contributor.departmentDBÜen_US
dc.identifier.issue2en_US
dc.identifier.volume64en_US
dc.identifier.startpage166en_US
dc.identifier.endpage171en_US
dc.contributor.authorID0000-0002-9754-5474en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record